SCHEMBL715019

SCHEMBL715019

NC(=O)C1CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2883675 1.00
SCHEMBL2017203 1.00
SCHEMBL29621847 0.98
Hydrochloric Acid SCHEMBL4173444 0.98
Hydrochloric Acid SCHEMBL4717526 0.98 KMT2A (0.72)
Hydrochloric Acid SCHEMBL4714834 0.98 KMT2A (0.72)
Hydrochloric Acid SCHEMBL3403055 0.98
Hydrochloric Acid SCHEMBL3398658 0.98
Hydrochloric Acid SCHEMBL14311790 0.98 KMT2A (0.72)
Trifluoroacetic Acid SCHEMBL23779156 0.86 KDM4E (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 570 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3565808-B1 COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS ARDELYX INC (US) 2026-03-04 EP claimed
EP-4323338-B1 TEAD INHIBITORS ORION CORP (FI) 2025-10-08 EP claimed
CN-119923391-A Targeted protein degradation of PARP14 for use in therapy 艾伯维新加坡运营私人有限公司 2025-05-02 CN claimed
EP-4543892-A1 FLUORESCENT PROBES FOR MAGL F. Hoffmann-La Roche AG (CH) 2025-04-30 EP claimed
EP-4543870-A1 NEW HETEROCYCLIC-CARBONYL-CYCLIC COMPOUNDS AS MAGL INHIBITORS F. Hoffmann-La Roche AG (CH) 2025-04-30 EP claimed
CN-119698278-A Small molecule modulators of alveolar type 2 cell proliferation for the treatment of pulmonary diseases 斯克里普斯研究学院 2025-03-25 CN claimed
EP-4086240-B1 PYRROLIDINONE HERBICIDES FMC CORP (US) 2025-02-05 EP claimed
CN-119301113-A Novel heterocyclic carbonyl cyclic compounds as MAGL inhibitors 豪夫迈·罗氏有限公司 2025-01-10 CN claimed
EP-4447681-A2 COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF Adama Agan Ltd. (IL) 2024-10-23 EP claimed
CN-115335369-B GEM-disubstituted piperidine melanocortin subtype-2 receptor (MC 2R) antagonists and uses thereof 克林提克斯医药股份有限公司 2024-07-02 CN claimed
CN-104427873-A Certain chemical entities, compositions, and methods NEUPHARMA INC 2015-03-18 CN claimed
WO-2014140310-A1 PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY AbbVie Deutschland GmbH & Co. KG (DE) 2014-09-18 WO claimed
CN-103442568-A Furo [3,2-d ] pyrimidine compounds ABBVIE INC 2013-12-11 CN claimed
EP-2245033-B1 PYRROLOPYRAZINE KINASE INHIBITORS HOFFMANN LA ROCHE (CH) 2011-08-31 EP claimed
EP-2245033-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2010-11-03 EP claimed
US-20100267666-A1 Pyrrolopyrazine kinase inhibitors ROCHE PALO ALTO LLC 2010-10-21 US claimed
WO-2010059922-A1 PYRROLIDINE CARBOXAMIDE COMPOUNDS LIGAND PHARMACEUTICALS INCORPORATED (US) 2010-05-27 WO claimed
WO-2009106441-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-09-03 WO claimed
EP-1615921-B1 PYRIDO 2,3-D PYRIMIDIN-7-CARBOXYLIC ACID DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS HOFFMANN LA ROCHE (CH) 2009-03-18 EP claimed
EP-1432702-B1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND THEIR USE AS RAF INHIBITORS SMITHKLINE BEECHAM PLC (GB) 2006-08-16 EP claimed